64 related articles for article (PubMed ID: 19845776)
1. Effect of glycoPEGylation on factor VIIa binding and internalization.
Sen P; Ghosh S; Ezban M; Pendurthi UR; Vijaya Mohan Rao L
Haemophilia; 2010 Mar; 16(2):339-48. PubMed ID: 19845776
[TBL] [Abstract][Full Text] [Related]
2. Activity and regulation of glycoPEGylated factor VIIa analogs.
Ghosh S; Sen P; Pendurthi UR; Rao LV
J Thromb Haemost; 2008 Sep; 6(9):1525-33. PubMed ID: 18624982
[TBL] [Abstract][Full Text] [Related]
3. Generation and biochemical characterization of glycoPEGylated factor VIIa derivatives.
Stennicke HR; Ostergaard H; Bayer RJ; Kalo MS; Kinealy K; Holm PK; Sørensen BB; Zopf D; Bjørn SE
Thromb Haemost; 2008 Nov; 100(5):920-8. PubMed ID: 18989539
[TBL] [Abstract][Full Text] [Related]
4. Factor VIIa binding to endothelial cell protein C receptor.
Rao LV; Pendurthi UR
Thromb Res; 2008; 122 Suppl 1(Suppl 1):S3-6. PubMed ID: 18691496
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium.
Ghosh S; Pendurthi UR; Steinoe A; Esmon CT; Rao LV
J Biol Chem; 2007 Apr; 282(16):11849-57. PubMed ID: 17327234
[TBL] [Abstract][Full Text] [Related]
6. Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7.
Chang GT; Kisiel W
Thromb Haemost; 1995 Feb; 73(2):231-8. PubMed ID: 7792735
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.
Clark CA; Vatsyayan R; Hedner U; Esmon CT; Pendurthi UR; Rao LV
J Thromb Haemost; 2012 Nov; 10(11):2383-91. PubMed ID: 22950420
[TBL] [Abstract][Full Text] [Related]
8. Factor VIIa induced release of von Willebrand factor from human umbilical vein endothelial cells by a tyrosine kinase dependent pathway.
Brown SA; Bowen DJ; Hallett MB; Giddings JC; Collins PW
Thromb Haemost; 2002 Jun; 87(6):1057-61. PubMed ID: 12083486
[TBL] [Abstract][Full Text] [Related]
9. Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa.
Karpf DM; Sørensen BB; Hermit MB; Holmberg HL; Tranholm M; Bysted BV; Groth AV; Bjørn SE; Stennicke HR
Thromb Res; 2011 Aug; 128(2):191-5. PubMed ID: 21429564
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor.
Vatsyayan R; Kothari H; Mackman N; Pendurthi UR; Rao LV
PLoS One; 2014; 9(8):e103505. PubMed ID: 25102166
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
Ogiwara K; Nogami K; Shima M
Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
[TBL] [Abstract][Full Text] [Related]
12. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
Edgington TS; Mackman N; Fan ST; Ruf W
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S15-27. PubMed ID: 1364116
[TBL] [Abstract][Full Text] [Related]
13. The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa.
Lisman T; de Groot PG
Blood Rev; 2015 Jul; 29(4):223-9. PubMed ID: 25553898
[TBL] [Abstract][Full Text] [Related]
14. Prolonged effect of GlycoPEGylated rFVIIa (40k-PEG-rFVIIa) in rabbits correlates to activity in plasma.
Johansen PB; Bjørn SE; Agersø H; Thorup I; Hermit MB; Sørensen B; Stennicke HR; Ezban M; Tranholm M
Thromb Haemost; 2010 Jul; 104(1):157-64. PubMed ID: 20390231
[TBL] [Abstract][Full Text] [Related]
15. The effect of GlycoPEGylation on the physical stability of human rFVIIa with increasing calcium chloride concentration.
Plesner B; Westh P; Nielsen AD
Eur J Pharm Biopharm; 2011 Jun; 78(2):222-8. PubMed ID: 21220008
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa.
Plesner B; Westh P; Nielsen AD
Int J Pharm; 2011 Mar; 406(1-2):62-8. PubMed ID: 21236324
[TBL] [Abstract][Full Text] [Related]
17. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
18. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
[TBL] [Abstract][Full Text] [Related]
19. The molar hydrodynamic volume changes of factor VIIa due to GlycoPEGylation.
Plesner B; Westh P; Hvidt S; Nielsen AD
J Pharm Biomed Anal; 2011 Jun; 55(3):597-602. PubMed ID: 21429688
[TBL] [Abstract][Full Text] [Related]
20. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
Almus FE; Rao LV; Rapaport SI
Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
